Ensuring children with epilepsy get vitamin D

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |July 22, 2016
    PubMed

    Insights

    Children with epilepsy require specific strategies to maintain adequate vitamin D levels. Research from Malaysia highlights the importance of targeted interventions for pediatric epilepsy patients.

    Area of Science:

    • Pediatric Neurology
    • Nutritional Science
    • Public Health

    Background:

    • Epilepsy is a common neurological disorder in children.
    • Vitamin D deficiency is a potential concern in this population.
    • Geographical factors, such as in Malaysia, may influence vitamin D status.

    Purpose of the Study:

    • To investigate the vitamin D status of children with epilepsy.
    • To identify factors affecting vitamin D levels in this cohort.
    • To propose targeted strategies for ensuring sufficient vitamin D.

    Main Methods:

    • Cross-sectional study design.
    • Biochemical assessment of serum vitamin D levels.
    • Analysis of demographic and clinical data.

    Main Results:

    • A significant proportion of children with epilepsy were found to have insufficient vitamin D levels.
    • Specific risk factors for deficiency were identified.
    • The findings underscore a need for proactive management.

    Conclusions:

    • Targeted vitamin D supplementation and monitoring strategies are crucial for children with epilepsy.
    • Healthcare providers should consider vitamin D status in the routine care of these patients.
    • Further research is warranted to optimize interventions.

    Related Concept Videos

    Vitamins01:30

    Vitamins

    Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
    2.8K
    Epilepsy and Seizures: Overview01:24

    Epilepsy and Seizures: Overview

    Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
    Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
    1.6K
    Antiepileptic Drugs: Calcium Channel Blockers01:17

    Antiepileptic Drugs: Calcium Channel Blockers

    Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
    Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
    1.5K
    Antiepileptic Drugs: Glutamate Antagonists01:14

    Antiepileptic Drugs: Glutamate Antagonists

    Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
    1.2K
    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
    1.1K
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    692